Emergency biventricular assist device implantation in a patient with suspected COVID‐19 disease

Autor: M. Charlesworth, S. M. Shaw, James Barnard, N. Nwaejike, M. Garcia, T. Strang
Rok vydání: 2020
Předmět:
Zdroj: Anaesthesia Reports
Anaesth Rep
ISSN: 2637-3726
DOI: 10.1002/anr3.12079
Popis: Summary Severe coronavirus disease 2019 (COVID-19) is a multisystem inflammatory disorder and knowledge and experience with severe acute respiratory failure in infected patients has grown considerably since reports of the first few cases Little is known about the effect of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus on the heart, and it has been suggested that fulminant cardiac failure, with or without respiratory failure, may occur several weeks following infection A young man presented after a recent viral illness He was in severe cardiogenic shock and was implanted with an emergency biventricular assist device, which also incorporated an extracorporeal membrane oxygenator He stabilised soon after and, despite an intracerebral haemorrhage which resolved and bleeding into the trachea following percutaneous tracheostomy, he survived to explant and was successfully stepped down to a rehabilitation unit on postoperative day 50 He tested positive for SARS-CoV-2 antibodies when the test became available on postoperative day 33 We envisage there will be many more such presentations of acute COVID-19-associated cardiogenic shock and we recommend clinicians consider this diagnosis when presented with an acutely unwell patient with an unclear diagnosis following a viral illness These patients should be discussed as early as possible with a transplant/mechanical circulatory support team
Databáze: OpenAIRE
Externí odkaz: